Carcinoma, Adenosquamous: all 63 studies

Page 1 of 1. Open to participants first (5), then studies with results posted, then the rest; newest registration first within each.

• Pembrolizumab Concurrent With and Following Carbon-ion Radiotherapy for Locally Advanced Cervical AdenocarcinomaNot yet recruitingNCT06805864Phase 2
• Reinforced and Non-Reinforced Staple Lines in Fissureless LobectomyNot yet recruitingNCT06602661Phase 1
• PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical CancerRecruitingNCT05581121Phase 3
• A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX07 Combination Therapy or Monotherapy in Patients With Advanced ESCCRecruitingNCT05221658Phase 2
• T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung CancerRecruitingNCT02133196Phase 2
• Nivolumab and Tumor Infiltrating Lymphocytes (TIL) in Advanced Non-Small Cell Lung CancerCompletedNCT03215810Phase 1Results posted
• Atezolizumab and Bevacizumab in Treating Patients With Recurrent, Persistent, or Metastatic Cervical CancerCompletedNCT02921269Phase 2Results posted
• A Study of Pemetrexed in Recurrent Cervical AdenocarcinomasTerminatedNCT02868892Phase 2Results posted
• Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical CancerCompletedNCT02164461Phase 1Results posted
• Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical CancerCompletedNCT01414608Phase 3Results posted
• Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for CervixCompletedNCT01365156Phase 3Results posted
• Akt Inhibitor MK2206 in Treating Patients With Recurrent or Advanced Endometrial CancerCompletedNCT01307631Phase 2Results posted
• Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical CancerCompletedNCT01266460Phase 2Results posted
• Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical CancerCompletedNCT01266447Phase 2Results posted
• Trebananib in Treating Patients With Persistent or Recurrent Endometrial CancerCompletedNCT01210222Phase 2Results posted
• Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial CancerCompletedNCT01132820Phase 2Results posted
• Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent SurgeryCompletedNCT01101451Phase 3Results posted
• Temsirolimus in Treating Patients With Cervical Cancer That Is Recurrent, Locally Advanced, Metastatic, or Cannot Be Removed By SurgeryCompletedNCT01026792Phase 2Results posted
• Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial CancerCompletedNCT01005329Phase 2Results posted
• Ixabepilone to Treat Cervical CancerTerminatedNCT00924066Phase 2Results posted
• Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial CancerCompletedNCT00820898Phase 2Results posted
• Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical CancerCompletedNCT00803062Phase 3Results posted
• Trial Of CP-751, 871 And Erlotinib In Refractory Lung CancerTerminatedNCT00673049Phase 3Results posted
• Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma HistologyTerminatedNCT00596830Phase 3Results posted
• Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and NeckTerminatedNCT00570674Phase 1/2Results posted
• Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial CancerCompletedNCT00416455Phase 1/2Results posted
• Sunitinib Malate in Treating Patients With Uterine Cervical Cancer That is Stage IVB, Recurrent, or Cannot Be Removed By SurgeryCompletedNCT00389974Phase 2Results posted
• Bevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced Cervical CancerCompletedNCT00369122Phase 2Results posted
• ABI-007 in Treating Patients With Persistent or Recurrent Cervical CancerCompletedNCT00309959Phase 2Results posted
• Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical CancerTerminatedNCT00262821Phase 3Results posted
• Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung CancerCompletedNCT00126581Phase 2Results posted
• Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial CancerCompletedNCT00072176Phase 2Results posted
• Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical CancerTerminatedNCT00070317Not applicableResults posted
• Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the CervixCompletedNCT00064077Phase 3Results posted
• Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine CorpusCompletedNCT00064025Phase 2Results posted
• Oxaliplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Cervical CancerCompletedNCT00057863Phase 2Results posted
• Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial CancerCompletedNCT00006011Phase 3Results posted
• RT for Cervical Adenocarcinoma/adenosquamous CarcinomaActive, not recruitingNCT06741046
• Multicenter Trial of ESK981 in Patients With Select Solid TumorsActive, not recruitingNCT05988918Phase 2
• A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in ChinaCompletedNCT05337163
• Pemigatinib in Subjects With Adenosquamous Carcinoma of the PancreasWithdrawnNCT05216120Phase 2
• Cabozantinib Plus Pembrolizumab for Recurrent, Persistent and/or Metastatic Cervical CancerTerminatedNCT04230954Phase 2
• Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive WomenWithdrawnNCT03834571Phase 2
• Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical CancerStatus unknownNCT03469531Phase 2
• The Potential for Metformin to Improve Tumor Oxygenation in Locally Advanced Cervix Cancer: A Phase II Randomized TrialCompletedNCT02394652Phase 2
• Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological CancersCompletedNCT02020707Phase 1
• MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical CancerTerminatedNCT01992861
• Hybrid PET/MR in the Therapy of Cervical CancerCompletedNCT01759355
• Chemoradiation Therapy and Ipilimumab in Treating Patients With Stages IB2-IIB or IIIB-IVA Cervical CancerCompletedNCT01711515Phase 1
• Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical CancerActive, not recruitingNCT01649089Not applicable
• Evaluation of Hysterectomy After Chemoradiation Therapy for Stage IB2/II Cervical CancerTerminatedNCT01363466Phase 3
• Study of Nimotuzumab, Radiation Therapy and Cisplatin Versus Radiation Therapy and Cisplatin for Treatment of Stage IB e IVA UCC(CORUS)WithdrawnNCT01301612Phase 2
• Cisplatin and Radiation Therapy Followed by Paclitaxel and Carboplatin in Treating Patients With Stage IB-IVA Cervical CancerStatus unknownNCT01295502Phase 1
• Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical CancerCompletedNCT01281852Phase 1
• Collecting Tumor Samples From Patients With Gynecological TumorsCompletedNCT00897442
• Impact of Positron Emission Tomography (PET) Imaging in Women With Locally Advanced Cervical Cancer (PET LACE Trial)CompletedNCT00895349Not applicable
• Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial CancerCompletedNCT00575952Phase 1
• Glycoprotein and Glycan in Tissue and Blood Samples of Patients With Stage IB-IVA Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal Lymph NodesCompletedNCT00460356
• Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical CancerCompletedNCT00104910Phase 1
• Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical CancerCompletedNCT00068549Phase 1
• Capecitabine in Treating Patients With Persistent or Recurrent Cervical CancerCompletedNCT00039442Phase 2
• Thalidomide in Treating Patients With Recurrent or Persistent Endometrial CancerCompletedNCT00025467Phase 2
• Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and AnemiaCompletedNCT00017004Phase 3

← Carcinoma, Adenosquamous overview